Náray-Fejes-Tóth A, Watlington C O, Fejes-Tóth G
Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756.
Endocrinology. 1991 Jul;129(1):17-21. doi: 10.1210/endo-129-1-17.
Aldosterone selectivity in mineralocorticoid target tissues has been suggested to be due to 11 beta-hydroxysteroid dehydrogenase (11-OHSD), which, by inactivating the endogenous glucocorticoids cortisol and corticosterone (CS), would allow aldosterone to bind to the mineralocorticoid receptor that has equal affinity for aldosterone and natural glucocorticoids. However, a recent immunohistochemical study failed to colocalize 11-OHSD and mineralocorticoid receptors in the kidney. The goal of this study was to determine 1) whether metabolism of CS occurs in the renal target cells of aldosterone, i.e. in cortical collecting duct cells, and 2) if it does so, whether this activity is sufficient to reduce intracellular CS levels to allow binding of aldosterone to the mineralocorticoid receptor. Cortical collecting duct cells were isolated by solid phase immunoadsorption, with a cell purity of approximately 98%. Metabolism of CS was studied in both freshly isolated cells and primary cultures grown as monolayers on permeable supports. Freshly isolated cells rapidly converted CS to 11-dehydro-CS, which was the only major metabolite detected. In intact collecting duct cells 11-OHSD had an apparent Km for CS of approximately 60 nM, a value more than 100-fold lower than the Km of 11-OHSD in the rat liver, and a maximum velocity of approximately 1.7 x 10(-14) mol/min.1000 cells. In cultured cells, when [3H]CS was applied to one side of the monolayer, almost all radioactivity on the opposite side was 11-dehydro-CS. The cells were able to almost completely metabolize CS passing through them for up to a concentration of 2.5 x 10(-7) M. Carbenoxolone, an inhibitor of 11-OHSD, reduced CS degradation by 88%. Neither freshly isolated nor cultured collecting duct cells converted [3H]11-dehydro-CS back to CS in a significant amount (less than 1%). These data provide functional evidence for 11-OHSD activity in renal aldosterone target cells and indicate that this enzyme might be a collecting duct-specific isoform of 11-OHSD which can sufficiently reduce intracellular CS concentrations to contribute to the apparent mineralocorticoid selectivity of the collecting duct.
有人提出,盐皮质激素靶组织中的醛固酮选择性归因于11β-羟基类固醇脱氢酶(11-OHSD),该酶通过使内源性糖皮质激素皮质醇和皮质酮(CS)失活,使醛固酮能够与对醛固酮和天然糖皮质激素具有同等亲和力的盐皮质激素受体结合。然而,最近一项免疫组织化学研究未能在肾脏中使11-OHSD与盐皮质激素受体共定位。本研究的目的是确定:1)CS的代谢是否发生在醛固酮的肾脏靶细胞中,即皮质集合管细胞中;2)如果发生,这种活性是否足以降低细胞内CS水平,以使醛固酮与盐皮质激素受体结合。通过固相免疫吸附分离皮质集合管细胞,细胞纯度约为98%。在新鲜分离的细胞和在可渗透支持物上单层生长的原代培养物中研究CS的代谢。新鲜分离的细胞迅速将CS转化为11-脱氢-CS,这是检测到的唯一主要代谢产物。在完整的集合管细胞中,11-OHSD对CS的表观Km约为60 nM,该值比大鼠肝脏中11-OHSD的Km低100多倍,最大速度约为1.7×10⁻¹⁴ mol/min·1000个细胞。在培养细胞中,当将[³H]CS施加到单层的一侧时,另一侧几乎所有的放射性都是11-脱氢-CS。这些细胞能够几乎完全代谢通过它们的CS,浓度高达2.5×10⁻⁷ M。11-OHSD抑制剂甘草次酸使CS降解减少88%。新鲜分离的或培养的集合管细胞均未将大量[³H]11-脱氢-CS(不到1%)转化回CS。这些数据为肾脏醛固酮靶细胞中的11-OHSD活性提供了功能证据,并表明该酶可能是11-OHSD的集合管特异性同工型,其能够充分降低细胞内CS浓度,从而有助于集合管明显的盐皮质激素选择性。